2021
DOI: 10.1016/j.jtho.2021.08.508
|View full text |Cite
|
Sign up to set email alerts
|

P47.15 A Phase IA Study of Ceritinib + Trametinib in Patients With Advanced ALK- or ROS1- Rearranged NSCLC: Preliminary Results

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles